• Cardiology, Diabetes & Nephrology
    • Cardiology, Diabetes & Nephrology – London
    • Cardiology, Diabetes & Nephrology – Brazil
    • Cardiology, Diabetes & Nephrology – Canada
    • Cardiology, Diabetes & Nephrology – USA
    • Hatter Horizon Series
    • The 18th Malvern Diabetic Foot Conference
    • Previous Events
      • CDNATL 2019 – London
      • CDNATL 2019 – Brazil
      • CDNATL 2018
      • CDNATL 2017
      • CDNATL 2016
      • CDNATL 2015
      • CDNATL 2014
      • CDATL 2013
      • CDATL 2012
      • NATL 2012
      • CDATL 2011
      • CDATL 2010
      • NATL 2010
      • CATL 2009
      • NATL 2009
  • Cell Therapy
    • Cell Therapy at the Limits 2021
  • Oncology
    • Previous Events
      • Accelerating Cancer Immunotherapy 2017
      • OATL 2016
      • OATL 2015
      • OATL 2014
      • OATL 2012
      • OATL 2011
      • OATL 2010
      • UCL Frontiers of Oncology 2019
        • Haematology
        • Melanoma
        • Urology
        • Women’s Health
        • Lung Cancer
        • Gastrointestinal Oncology
  • Multiple Sclerosis
    • Multiple Sclerosis at the Limits 2021
    • Multiple Sclerosis Nurses at the Limits 2021
    • Previous events
      • Multiple Sclerosis at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2020
      • Multiple Sclerosis Nurses at the Limits 2019
      • MSATL 2018: Introduction
      • MSATL 2017: Introduction
  • About
    • Academic Founders
    • Independence
    • The Lancet
    • Support & Sponsorship
    • Delegate Invitations
  • Supporters
  • Archive
    • CDNATL 2019 – London
    • CDNATL 2019 – Brazil
    • Multiple Sclerosis at the Limits 2018
    • Multiple Sclerosis at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2020
    • Multiple Sclerosis Nurses at the Limits 2019
    • Hatter Horizon Series
      • Horizon GP Programme 2019
      • Hatter Horizon Series 2019
      • Hatter Horizon Series 2018
      • Hatter Horizon Series 2017
    • Cardiology, Diabetes & Nephrology at the Limits 2018
    • Accelerating Cancer Immunotherapy 2017
    • Oncology at the Limits 2017

Friday 18th & Saturday 19th January 2019
The Royal College of Physicians, London, UK

 


Friday 18th January
13:00
Badge collection and buffet lunch
14:00
Introduction
Mrs Karen Vernon
MS Nurse Consultant at Salford Royal NHS Foundation Trust
14:20
Multiple Sclerosis research at the limits
To B or not to B – a definitive guide to B Cells in MS
Professor Gavin Giovannoni
Chair of Neurology, Barts and The London School of Medicine and Dentistry, London, UK
15:00
Stem cell therapy in MS – re-booting the immune system to defeat MS
Professor Basil Sharrack
Consultant Neurologist and Honorary Professor of Clinical Neurology, The University of Sheffield, UK
15:40
Break
16:05
The identification of potential treatment targets in advancing MS
Professor Bruno Stankoff
Professor of Neurology at Pierre and Marie Curie University, Paris, France
16:45
Progressive MS
Novel Therapeutic approaches to Primary Progressive MS
Dr Eli Silber
Neurology Consultant, King’s College NHS Foundation Trust, London, UK
17:25
Close
19:30
Conference Dinner with Guest Speaker
Ms Caroline Wyatt
Saturday 19th January
08:30
Progressive MS contd.
A review of ongoing trials in SPMS
Dr Jeremy Chataway
UCL Institute of Neurology, London, UK
09:10
New technology
Living with the App; patient portals & online management of MS
Dr Lorna Paul
Professor of Allied Health Science, School of Health and Life Sciences, Glasgow Caledonian University, Scotland, United Kingdom
09:50
Break
10:15
Lifestyle & environmental factors
Interactions with multiple sclerosis risk genes
Professor Tomas Olsson
Professor/Senior Physician, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
Lifestyle & environmental factors affecting MS
Dr Trevor Pickersgill
Consultant Neurologist, Cardiff and Vale University Health Board, Wales, UK
10:55
Lifestyle & environmental factors Q&A
A guide to ongoing clinical trials in MS, including new biomarkers
Dr Martin E Duddy
Clinical Director and Consultant Neurologist, The Royal Victoria Infirmary, Newcastle upon Tyne, UK
11:50
Should all MS patients be treated with DMTs?
Created by Dr Gordon Mazibrada and Presented in his absence by Dr Trevor Pickersgill & Dr Martin Duddy
Consultant Neurologist Queen Elizabeth Hospital, Birmingham, UK
12:30
Summary: MS Nurses can never have too much education
Mrs Karen Vernon
MS Nurse Consultant at Salford Royal NHS Foundation Trust

The 18th Malvern Diabetic Foot Conference
Wednesday, 7 – Friday, 9 July 2021, Malvern, UK

Multiple Sclerosis Nurses
at the Limits

Friday, 10 & Saturday, 11 September 2021, London, UK

Multiple Sclerosis at the Limits
Monday, 13 & Tuesday, 14 September 2021, London, UK

Hatter Horizon GP Meeting
Monday, 1 November 2021
London, UK

Cell Therapy at the Limits 2021
Monday, 8 & Tuesday, 9 November 2021, London, UK

Hatter Horizon Series
Monday, 22 November 2021, London, UK

Cardiology, Diabetes & Nephrology at the Limits Brazil
Friday, 10 - Saturday, 11 December 2021, São Paulo, Brazil

Cardiology, Diabetes & Nephrology at the Limits 2022
Monday, 4 & Tuesday, 5 April 2022, London,UK

Cardiology, Diabetes & Nephrology at the Limits Canada
Tuesday, 24 & Wednesday, 25 May 2022, Toronto, Canada

Policy links

  • Medical Disclaimer
  • Disclosure
  • E-mail Policy
  • Privacy Policy
  • Anti-spam Policy
  • Disclaimer
  • External Links Policy
  • Terms of use
  • Contact
  • The Lancet
  • UCL
  • UCT
  • Brigham & Women’s Hospital
  • The University of Campinas
© 2021 At the Limits Ltd.
This site uses cookies More info